March 2024: Revolution in Diabetes, Painless Smartpatch

Medicsen revolutionizes diabetes treatment with a painless Smartpatch.

Image credits: Medicsensors S.L

In the ever-evolving field of healthcare technology, Medicsen emerges as a bold innovator, shaping the future for people living with diabetes. Driven by the desire to eliminate the pain and inconvenience associated with traditional diabetes management, Medicsen has developed a revolutionary solution: the Medicsen Smartpatch.

Imagine, a world where managing diabetes is painless, discreet, and personalized. The Medicsen Smartpatch makes this vision a reality. This needle-free, wearable device acts as a smart companion, simulating the functions of the pancreas and delivering essential medications directly through the skin.

Utilizing harmless waves, the Smartpatch painlessly opens natural skin pores, allowing macromolecules like insulin and heparin to enter the body. This innovative technology ensures maximum comfort and discretion, tucked away in a small, wearable device.

Image credits: Medicsensors S.L

About Medicsen

Medicsen was founded in 2023 and has quickly developed into an award-winning start-up in the field of medical technology. The company specializes in pain-free drug delivery through the skin and wearable devices for patients with chronic diseases. The company focuses on developing user-friendly and pain-free solutions for a better quality of life.

Sam Draper
March 1, 2024

March 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

This App Combines AI and Biosensors to Detect COVID-19 in Two Minutes, Even in Asymptomatic Patients

NeuTigers, an Artificial Intelligence company spun out of Princeton University, launched Covid...

Abbott to Ramp Up Production of its FreeStyle Libre Continuous Glucose Monitor

Abbott is planning to significantly ramp up manufacturing for its lower-cost CGM.

Neurolief’s Relivion Smart Headband for Migraine Treatment Receives CE Approval

Neurolief received CE mark for its Relivion™ non-invasive, adaptive digital treatment for migraine.

Abbott Aims to Gain Ground in Valve Replacements

In an attempt to catch up in valve replacements after Boston Scientific's recent global withdrawal.
Discover more